Clinical trial
A Phase 3 Open-label Study of Infacort® in Neonates, Infants and Children Less Than 6 Years of Age With Adrenal Insufficiency
NCT02720952 is registered in ClinicalTrials.gov with Neurocrine UK Limited as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase 3 Open-label Study of Infacort® in Neonates, Infants and Children Less Than 6 Years of Age With Adrenal Insufficiency
- Lead sponsor
- Neurocrine UK Limited
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- March 31, 2015
- Completion date
- July 31, 2016
- Enrollment
- 24 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.